Ani Pharmaceuticals (ANIP) Accumulated Expenses (2010 - 2026)
Ani Pharmaceuticals (ANIP) posted Accumulated Expenses of $13.7 million for Q1 2026, down 63.76% sequentially from $37.9 million in Q4 2025, and down 38.4% YoY from $22.3 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Accumulated Expenses (2010 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Accumulated Expenses for 17 years, with the latest figure at $13.7 million in Q1 2026.
- Quarterly Accumulated Expenses fell 38.4% year-over-year to $13.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.7 million (down 38.4% YoY) and the FY2025 annual result came in at $37.9 million, changed 0.46% from the prior year.
- Accumulated Expenses fell to $13.7 million in Q1 2026 per ANIP's latest filing, from $37.9 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $37.9 million in Q4 2025 and troughed at $4.8 million in Q1 2023.
- A 5-year average of $15.5 million and a median of $11.5 million in 2022 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2023 and 2024: Accumulated Expenses slumped 53.6% in 2023, then soared 469.57% in 2024.
- Over 5 years, Accumulated Expenses stood at $10.3 million in 2022, then jumped by 130.66% to $23.8 million in 2023, then soared by 58.6% to $37.7 million in 2024, then grew by 0.46% to $37.9 million in 2025, then plunged by 63.76% to $13.7 million in 2026.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $13.7 million, $37.9 million, and $14.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.15 Mn |
| Mar 31, 2026 | 13.74 Mn |
| Dec 31, 2025 | 37.90 Mn |
| Sep 30, 2025 | 13.95 Mn |
| Jun 30, 2025 | 14.76 Mn |
| Mar 31, 2025 | 22.30 Mn |
| Dec 31, 2024 | 37.73 Mn |
| Sep 30, 2024 | 29.78 Mn |
| Jun 30, 2024 | 6.92 Mn |
| Mar 31, 2024 | 9.53 Mn |
| Dec 31, 2023 | 23.79 Mn |
| Sep 30, 2023 | 5.23 Mn |
| Jun 30, 2023 | 5.34 Mn |
| Mar 31, 2023 | 4.80 Mn |
| Dec 31, 2022 | 10.31 Mn |
| Sep 30, 2022 | 7.75 Mn |
| Jun 30, 2022 | 11.51 Mn |
| Mar 31, 2022 | 8.13 Mn |
| Dec 31, 2021 | 8.52 Mn |
| Sep 30, 2021 | 4.54 Mn |